We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Illustration

First-Ever Commercially Available COVID-19 Seroconversion Panel to Confirm Presence of Anti-SARS-CoV-2 Antibodies Completed

Access Biologicals (Vista, CA, USA) has completed the first-ever commercially available COVID-19 seroconversion panel to confirm the presence of anti-SARS-CoV-2 antibodies that will assist diagnostic manufacturers and researchers during assay development and evaluation, as well as troubleshooting COVID-19-test methods. More...
08 Sep 2020
Image: Researchers from the Faculty of Medicine of The Chinese University of Hong Kong (Photo courtesy of The Chinese University of Hong Kong)

Stool Test Could Better Detect COVID-19 than Traditional Nose Swabs Due to Prolonged Gut Viral Infection

Researchers have found for the first time that COVID-19 patients have active and prolonged gut viral infection, suggesting that stool tests could be more safe, accurate and non-invasive than traditional nose swabs in detecting coronavirus. More...
08 Sep 2020
Illustration

Groundbreaking RNA Extraction-Free qSanger-COVID-19 Assay Secures FDA EUA

A groundbreaking SARS-CoV-2 diagnostic test which eliminates the costly and time-consuming step of RNA extraction has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA). More...
08 Sep 2020
Image: MobileDetect Bio (MD-Bio) BCC19 COVID-19 test kit (Photo courtesy of DetectaChem)

COVID-19 Test Kit Using Portable Technology with Mobile App Result Reporting Secures FDA EUA

A new groundbreaking COVID-19 test kit that uses portable technology along with mobile app result reporting has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA). More...
07 Sep 2020
Illustration

Oversensitive COVID-19 Tests Detecting Dead Coronavirus Cells, Driving False Positives and Reinfections

A study by the Oxford University’s Centre for Evidence-Based Medicine (Oxford, England) suggests that the current COVID-19 diagnostic tests could be too sensitive and may be detecting dead coronavirus cells, leading to overestimated infections. More...
07 Sep 2020
Image: Roche Cobas 8800 System (Photo courtesy of Roche)

Roche Receives FDA EUA for Cobas SARS-CoV-2 & Influenza A/B Test for Use on Cobas 6800/8800 Systems

Roche’s (Basel, Switzerland) cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 Systems has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA). More...
07 Sep 2020
Image: MatMaCorp’s Solas 8 portable detection system for SARS-CoV-2 (Photo courtesy of MatMaCorp)

NIH Offers USD 129.3 Million in Scale-Up and Manufacturing Support for New Set of COVID-19 Testing Technologies

The National Institutes of Health (NIH Bethesda, MA, USA) has announced USD 129.3 million in scale-up and manufacturing support for a new set of COVID-19 testing technologies as part of its Rapid Acceleration of Diagnostics (RADx) initiative. More...
04 Sep 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.